|Bid||1.5000 x 100|
|Ask||2.4400 x 1000|
|Day's Range||1.8000 - 2.0100|
|52 Week Range||0.4900 - 3.0500|
|PE Ratio (TTM)||-3.07|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Investors certainly have to be happy with Galectin Therapeutics Inc (GALT) and its short term performance
Henry Schein, Inc. (HSIC) is expected to report first-quarter 2017 results on May 2, before the opening bell.
Myriad Genetics, Inc. (MYGN) is scheduled to report third-quarter fiscal 2017 results on May 2, after the closing bell.